71
10
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19584L |
TNF-α (31-45), human acetate
TNF-α (31-45), human acetate(144796-71-4 free base) |
Others | Others |
TNF-α (31-45), human acetate(144796-71-4 free base) 是一种肿瘤坏死因子-α 的肽。 | |||
T36127 |
TNF-α Antagonist
|
||
TNF-α antagonist is an exocyclic peptide that mimics the critical TNF-α recognition loop on TNF receptor I complex and, thus, prevents ligand interaction with the receptor. By blocking the TNF receptor ligand contact site, this peptide interferes with both activating receptor activator of NF-κB (RANK) and TNF-α's recruitment and activation of osteoclasts. TNF-α antagonist has been used to block bone resorption in the study of systemic bone loss in rheumatoid arthritis and inflammatory bone destr... | |||
T83628 |
TNF/IFNγ-IN-1
|
Antioxidant; TNF; COX | Apoptosis; Immunology/Inflammation; Neuroscience; oxidation-reduction |
TNF/IFNγ-IN-1(TGA) 是 TNF 和 IFN-γ 的双重抑制剂。TNF/IFNγ-IN-1 具有潜在的抗氧化和抗炎活性,可用于类似阿尔茨海默等的神经退行性疾病。 | |||
T77494 |
TNF-α-IN-9
|
TNF | Apoptosis |
TNF-α-IN-9 是一种 NDM-1 inhibitor-3类似物,是一种 TNF-α 抑制剂。TNF-α-IN-9 显示低抑制活性。 | |||
T9192 |
BIIB068
|
BTK | Angiogenesis; Tyrosine Kinase/Adaptors |
BIIB068 是可逆的、选择性的、具有口服活性的 BTK 抑制剂 (IC50:1 nM;Kd:0.3 nM)。它对 BTK 的选择性比其他激酶高 400 倍。它可用于自身免疫性疾病的研究。 | |||
T8316 |
1V209
TLR7 agonist T7 |
TLR | Immunology/Inflammation |
1V209 (TLR7 agonist T7) 是一种 Toll 样受体 7 (TLR7) 激动剂,可与各种多糖缀合,以改善其水溶性,增强功效并保持低毒性,具有抗肿瘤作用。 | |||
T6649 |
(S)-(+)-Rolipram
(S)-Rolipram,(+)-Rolipram,盐酸环胞苷,S- (+)-Rolipram |
Apoptosis; PDE | Apoptosis; Metabolism |
(S)-(+)-Rolipram ((+)-Rolipram) 是一种 cAMP 依赖性磷酸二酯酶 4 (PDE4) 抑制剂,IC50=1100 nM。它能够抑制人单核细胞产生的肿瘤坏死因子 α (TNFα)。 | |||
T0137 |
Mirtazapine
米氮平,6-Azamianserin,Org3770 |
Dopamine Receptor; 5-HT Receptor; Opioid Receptor; Adrenergic Receptor; Histamine Receptor | Endocrinology/Hormones; GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Mirtazapine (6-Azamianserin) 是一种有效的具有口服活性的去甲肾上腺素能和特异性血清素能抗抑郁剂 (NaSSA)。它也是一种5-HT2、5-HT3、组胺 H1 受体和 α2-肾上腺素受体拮抗剂,pKi 值分别为 8.05、8.1、9.3 和 6.95。 | |||
T40321 | TNF-α-IN-6 | ||
TNF-α-IN-6 is an orally efficacious allosteric inhibitor of TNFα ( K D = 6.8 nM). | |||
T16501 |
PF-3644022
|
p38 MAPK; Serine Protease; MAPK | MAPK; Proteases/Proteasome |
PF-3644022 是可口服的,具有 ATP 竞争性的MAPKAPK2 (MK2)选择性抑制剂,IC50为 5.2 nM,Ki 为 3 nM。它有效抑制 TNFα 的产生并具有抗炎作用,还抑制 MK3 和 p38 调节/激活激酶,IC50分别为 53 和 5.0 nM。 | |||
T9034 |
MK2-IN-3
MK2 Inhibitor III |
MAPK | MAPK |
MK2-IN-3 (MK2 Inhibitor III) 是选择性的 MAPKAP-K2 (MK-2)抑制剂(IC50:8.5 nM),能够抑制 U937 细胞及体内 TNFα 的生成。 | |||
T71726 |
TNFalpha-IN-S10
|
||
TNFalpha-IN-S10 is an inhibitor of TNF-α. | |||
T36097 | TNF-α-IN-2 | ||
TNF-α-IN-2 is a highly potent and orally bioavailable inhibitor of tumor necrosis factor alpha (TNFα), exhibiting an IC50 of 25 nM in the HTRF assay. It exerts its inhibitory effects by inducing conformational changes in the TNFα trimer upon binding, resulting in disrupted signaling when the trimer interacts with TNFR1. TNF-α-IN-2 holds promise as a valuable tool for investigating the pathogenesis of rheumatoid arthritis[1]. | |||
TP1537 |
TNF-α (10-36), human
|
||
TNF-α (10-36), human is a potent pro-inflammatory cytokine involved in the acute phase stress response. | |||
T79025 | TNF-α-IN-10 | ||
TNF-α-IN-10 (compound 8a) 作为IL-6与TNF-α的抑制剂,表现出抗炎活性。 | |||
TP1626 |
TNF-α (46-65), human
|
||
Human TNF alpha (46-65) peptide. | |||
T19584 |
TNF-α (31-45), human
|
Others | Others |
TNF-α (31-45), human is a peptide of tumor necrosis factor-α. | |||
T20033 |
Direct Violet 1
NSC75778,NSC 75778,Airedale Violet ND,NSC-75778,直接青莲N,Direct Violet N,CCRIS 2413 |
SARS-CoV | Microbiology/Virology |
Direct Violet 1 (CCRIS 2413) 是一种偶氮染料,是纺织品染料,也是 SARS-CoV-2 刺突蛋白和 ACE2 抑制剂之间的蛋白质相互作用 ,IC50为 1.47-2.63 µM。 | |||
T80973 |
TNF-α-IN-8
|
||
TNF-α-IN-8 (compound I-42) 作为一种TNF-α抑制剂,属于异吲哚-亚胺类化合物,适用于肿瘤、心脏病、骨质疏松、炎症、过敏及自身免疫性疾病的研究。作为点击化学试剂,其Azide基团能与含Alkyne的分子配对,通过铜催化的叠氮-炔环加成反应(CuAAc)产生反应,也可与含DBCO或BCN基团的分子进行菌株促进的炔-叠氮环加成反应(SPAAC)。 | |||
T78730 |
TNF-α-IN-11
|
||
TNF-α-IN-11 (Compound 10)是一种TNF-α抑制剂, KD值为12.06 μM。该化合物通过结合TNF-α并阻断其诱发的caspase和NF-κB信号通路激活,来实现其抑制作用。其具体机制包括抑制IκBα磷酸化和NF κB p65的核转位,适用于研究TNF-α介导的自身免疫性疾病。 | |||
T13175 |
TNF-α-IN-1
|
TNF | Apoptosis |
TNF-α-IN-1是 TNF-α 抑制剂。 | |||
T76026 |
TNF-α (31-45), human TFA
|
||
TNF-α (31-45), human TFA 是人肿瘤坏死因子-α 的多肽片段。TNF α 是一种炎性细胞因子,可诱导坏死或凋亡。 | |||
T9537 |
N'-Nitro-D-arginine
N'-Nitro-D-arginine,H-D-Arg(NO2)-OH,(R)-2-Amino-5-(3-nitroguanidino)pentanoic acid,N'-硝基-D-精氨酸 |
Others | Others |
N'-Nitro-D-arginine (N'-Nitro-D-arginine) 是一种砌块。 | |||
T76029 |
TNF-α (46-65), human TFA
|
||
TNF-α (46-65), human (TFA) 是人 TNF-α 的多肽片段。 | |||
T7162 |
R1487 Hydrochloride
R1487 (Hydrochloride) |
p38 MAPK; Autophagy | Autophagy; MAPK |
R1487 Hydrochloride (R1487(Hydrochloride)) 是一种可口服的高选择性 p38α 抑制剂,对 p38α 和 p38β 的Kd 值分别为 0.2 nM 和 29 nM。 | |||
T78272 |
Anti-Mouse TNF alpha Antibody (TN3-19.12)
|
||
Anti-Mouse TNF alpha Antibody为Rat宿主源的IgG类针对小鼠TNF alpha的抗体抑制剂。 | |||
TP1636 |
TNF-α (31-45), human TFA (144796-71-4 free base)
TNF-α (31-45), human TFA |
||
TNF-α (31-45), human (TFA) is a peptide of tumor necrosis factor-α. | |||
T78434 |
Mca-(endo-1a-Dap(Dnp))-TNF-Alpha (-5 to +6) amide (human) TFA
|
||
Mca-(endo-1a-Dap(Dnp))-TNF-Alpha (-5 to +6) amide (human) TFA 为基于荧光共振能量转移的多肽底物,通过裂解引起的荧光强度变化来确定其活性。 | |||
TP1669 |
TNF-α (46-65), human TFA (144796-72-5 free base)
TNF-α (46-65), human TFA |
||
TNF-α (46-65), human (TFA) is a peptide of human TNF-α. | |||
T81838 |
Mca-(endo-1a-Dap(Dnp))-TNF-Alpha (-5 to +6) amide (human)
|
||
Mca-(endo-1a-Dap(Dnp))-TNF-Alpha (-5 to +6) amide (human) 为一种基于FRET (荧光共振能量转移) 原理的多肽底物,通过其裂解引起的荧光强度变化来评估其活性。 | |||
TP1479 |
TNF-α (10-36), human (TFA) (144796-70-3 free base)
TNF-α (10-36), human (TFA) |
||
TNF-α (10-36), human (TFA) is a peptide of human TNF-α. | |||
T1934 |
Bay 11-7085
BAY 11-7083 |
Apoptosis; IκB/IKK; Ferroptosis; NF-κB | Apoptosis; NF-κB |
Bay 11-7085 抑制NF-κB 激活和IκBα磷酸化,其稳定 IκBα 的IC50值为 10 μM。 | |||
T4637 |
R-7050
TNF-α Antagonist III |
TNF | Apoptosis |
R-7050 (TNF-α Antagonist III) 是一种肿瘤坏死因子受体拮抗剂,对 TNFα具有更高选择性。 | |||
T14848 |
C 87
|
Others; TNF | Apoptosis; Others |
C 87 是一种小分子 TNF-α 抑制剂。 C 87 直接与 TNFα 结合,有效抑制 TNF-α 诱导的细胞毒性 (IC50 = 8.73 μM),并有效阻断 TNF-α 触发的信号传导活动。 | |||
T29857 |
Alethine
β-Alethine |
TNF | Apoptosis |
Alethine (β-Alethine) 是一种小分子化合物,具有抗肿瘤活性,可用于治疗肿瘤和感染。 Alethine 诱导的TNFα上调增加T 细胞的细胞毒性。 | |||
T4403 |
AX-024 hydrochloride
AX-024 HCl |
IL Receptor; TNF; COX; IFNAR; Interleukin | Apoptosis; Immunology/Inflammation; Neuroscience |
AX-024 hydrochloride (AX-024 HCl) 是一种细胞因子释放抑制剂,可强烈抑制 IL-6、TNFα、IFN-γ、IL-10 和 IL-17A 的产生。它是口服可利用的 TCR-Nck 相互作用抑制剂,可选择性地抑制 TCR 触发的 T 细胞活化。它通过靶向 SH3结构域调节细胞信号传导,具有低毒、高效和高选择性的特点。 | |||
T1902 |
BAY 11-7082
BAY 11-7821 |
Apoptosis; Others; IκB/IKK; DUB; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; NF-κB; Others; Ubiquitination |
BAY 11-7082 (BAY 11-7821) 是一种 NF-κB 抑制剂,可抑制 TNFα 诱导的 IκBα 磷酸化 (IC50=10 μM)。BAY 11-7082 也是一种泛素特异性蛋白酶 USP7 和 USP21 的抑制剂 (IC50=0.19/0.96 μM)。 | |||
T61111 |
UCB-5307
|
TNF | Apoptosis |
UCB-5307 是一种小分子化合物,可在体外抑制 TNFR1 信号转导和下游功能。 人 TNFα 的 KD 为 9 nM。 TNF 直接通过缓慢的结合动力学结合,KD = 6 nM。 UCB-5307 可以通过预制的 hTNF/hTNFR1 复合物。 | |||
T76711 |
Golimumab
MK-8259,SCH 900259,CNTO-148 |
TNF | Apoptosis |
Golimumab (CNTO-148) 是一种有效的人源化抗 TNFα IgG1κ单克隆抗体 。Golimumab 具有抗炎和抗癌活性,对 IL-6 和 IL-1β 的产生有抑制作用,可诱导细胞凋亡。Golimumab 可用来预防炎症发生和软骨或骨骼的破坏,可用于研究类风湿性关节炎和癌症。 | |||
T36524 |
IKK2-IN-4
5-Phenyl-2-ureidothiophene-3-carboxylic Acid Amide,IKK2 Inhibitor IV |
IκB/IKK; TNF | Apoptosis; NF-κB |
IKK2-IN-4 (IKK2 Inhibitor IV)是一种高效的 IKK-2 抑制剂,IC50 值为 25 nM。IKK2-IN-4 对 LPS 诱导的 PBMC 中 TNFα 的产生有抑制作用。 | |||
T38361 |
GSK717
|
IL Receptor; NOD | Immunology/Inflammation; NF-κB |
GSK717 是 NOD2(核苷酸结合寡聚结构域 2) 的选择性抑制剂。它抑制壁酰二肽 (MDP) 诱导的 NOD2 介导的信号转导,抑制 MDP 刺激的 HEK293/hNOD2 细胞分泌 IL-8 (IC50为 400 nM)。 | |||
T24185 |
IW-927
IW927,IW 927 |
||
IW-927 is a potent and selective TNFα/TNFRc1 interaction antagonist. | |||
T68321 |
AS1940477
|
||
AS1940477 is p38 MAPK inhibitor. AS1940477 inhibited the enzymatic activity of recombinant p38α and β isoforms but showed no effect against other 100 protein kinases including p38γ and δ isoforms. In human peripheral blood mononuclear cells, AS1940477 inhibited lipopolysaccharide (LPS)- or phytohemagglutinin A (PHA)-induced production of proinflammatory cytokines, including TNFα, IL-1β, and IL-6 at low concentrations (LPS/TNFα, IC(50)=0.45n M; PHA/TNFα, IC(50)=0.40 nM). In addition, equivalent c... | |||
T61810 | Anti-inflammatory agent 16 | ||
Anti-inflammatory agent 16 (compound 14) is a highly effective peptidomimetic with potent anti-inflammatory properties. It effectively reduces the expression levels of TNFα, NO, CD40, and CD86 [1]. | |||
T77179 | Remtolumab | ||
Remtolumab (ABT-122) 是一种双变量域免疫球蛋白,可以中和肿瘤坏死因子α (TNFα) 和IL-17A。Remtolumab 显示出对 TNFα 和IL-17A 的双重抑制。Remtolumab 可用于类风湿关节炎 (RA) 研究。 | |||
T68266 | BMS-751324 | ||
BMS-751324 是一种p38αMAPK 抑制剂。BMS-751324 含有氨基甲酰基亚甲基连接的前体,含有羟基苯基乙酸 (HPA) 衍生的酯和磷酸盐官能团。BMS-751324 在关节炎大鼠模型中有效抑制足部肿胀,并抑制 LPS 诱导的 TNFα 的生成。 | |||
T79170 |
Immuno modulator-1
|
||
Immuno modulator-1 (compound 22) 在hPBMC中抑制TNFα和IL-2的分泌,IC50为4.7 nM和26 nM。同时,该化合物对hERG钾通道具阻断活性,3 μM浓度时抑制率达20%。 | |||
T78991 |
Biotin-labeled ODN 1585 sodium
|
||
Biotin-labeled ODN 1585 (sodium) 作为一种有效的IFN和TNFα产生诱导剂,能够通过生物素检测系统与光学显微镜评估CpG ODN在细胞内的摄取与定位。 | |||
T27687 |
JNJ525
JNJ 525,JNJ-525 |
||
JNJ525 is an inhibitor of TNFα. JNJ525 inhibits protein function via an aggregation-based mechanism. JNJ525 prevents the formation of TNFα complexes with TNFR1 and TNFR2, the apparent IC50 values for the inhibition of complex formation are 1.2 ± 0.2 μM an | |||
T77126 | Ozoralizumab | ||
Ozoralizumab (ATN-103) 为一种针对TNFα的人源化抗体。该化合物为一种三价人源化纳米抗体,由两个针对人TNFα的纳米抗体和一个针对人血清白蛋白(HSA)的纳米抗体构成,适用于关节炎研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5834 |
Myrcene
|
Others | Others |
Myrcene 是具有可挥发性的芳香族化合物,对 TNFα 诱导的 NF-κB 具有抑制作用,且具有抗侵袭的能力。 | |||
T3918 |
Ginsenoside Rb3
人参皂苷 Rb3,Gypenoside IV,人参皂苷Rb3 |
NF-κB; COX; NO Synthase | Immunology/Inflammation; Neuroscience; NF-κB |
Ginsenoside Rb3 (Gypenoside IV) 是从三七中提取的一种天然产物。它在 293T 细胞系中抑制 TNFα 诱导的NF-κB 转录活性,IC50为 8.2 μM。它还抑制COX-2和iNOSmRNA 的诱导。 | |||
TN1637 |
Eurycomalactone
|
Anti-infection; NF-κB | Microbiology/Virology; NF-κB |
Eurycomalactone 是一种NF-κB 抑制剂,IC50=0.5 μM,是一种天然产物。它可抑制蛋白合成,降低 cyclin D1 蛋白水平,但对 TNFα 诱导的 IκBα 降解或 IKKα/β 和 IκBα 的磷酸化水平没有作用。 | |||
T2878 |
Ginsenoside Rd
Panaxoside Rd,Sanchinoside Rd,人参皂苷Rd,人参皂苷 Rd,Gypenoside VIII |
P450; Calcium Channel; NF-κB; COX; Endogenous Metabolite | Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; Neuroscience; NF-κB |
Ginsenoside Rd (Gypenoside VIII) 抑制 TNFα 诱导的NF-κB 转录活性,还抑制COX-2和iNOSmRNA 的表达。它抑制CYP2D6、CYP1A2、CYP3A4和CYP2C9,也抑制Ca2+内流,有可能抑制或阻止肿瘤生长。 | |||
T7917 |
4'-Hydroxychalcone
4-羟基查耳酮,4′-羟基查耳酮,2-Benzal-4-Hydroxyacetophenone |
Proteasome | Proteases/Proteasome; Ubiquitination |
4'-Hydroxychalcone (2-Benzal-4-Hydroxyacetophenone) 是从甘草根中分离的一种查尔酮,具有保护肝脏的作用。它能诱导大鼠离体肝线粒体囊泡快速释放钾,并引起其线粒体呼吸控制和氧化磷酸化衰退。它能通过抑制蛋白酶体 (proteasome),抑制TNFα 诱导的 NF-κB 活性。 | |||
T8852 |
tubuloside B
|
Apoptosis; Others | Apoptosis; Others |
Tubuloside B 是可从管花肉苁蓉茎中分离出的一种天然产物,具有抗氧化活性,可抑制TNFα 诱导的细胞凋亡。 | |||
T79961 |
Aloeresin G
|
||
Aloeresin G, 分离自Aloe的一种色原酮苷,对TNFα诱导的NF-κB转录活性具有抑制效果,其IC 50为40.02 μM。 | |||
T79962 |
Aloenin aglycone
|
Others | Others |
Aloenin aglycone (compound 13) 作为一种NF-κB抑制剂,可从芦荟渗出液中提取。它在抑制TNFα引发的NF-κB转录活性方面表现显著(IC50: 18.7 μM)。当HepG2细胞经10 ng/mL TNFα处理时,以10 μM Aloenin aglycone处理能有效下调诱导型一氧化氮合酶(iNOS)及细胞间粘附分子1(ICAM-1)的基因表达。 | |||
TN3614 |
Cearoin
檀木 |
ERK; BCL; PARP; IκB/IKK; TNF; NF-κB; ROS; Caspase | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; Immunology/Inflammation; MAPK; NF-κB; Proteases/Proteasome |
Cearoin has anti-inflammatory, and antiallergic activities, it can markedly inhibit inflammatory responses including LPS-induced NO production by suppressing the expression of iNOS mRNA and LPS-induced mRNA expression of TNFα and CCL2. Cearoin induces aut | |||
TN5880 |
Mesuol
|
||
Mesuol has antioxidant activity, it shows very high scavenging activity against DPPH radical; it also has immunomodulatory activity, can potentiate percentage neutrophil adhesion in neutrophil adhesion test in rats and phagocytosis in carbon clearance assay. Mesuol can suppress HIV-1 replication in Jurkat T cells, it inhibits TNFα-induced HIV-1-LTR transcriptional activity by targeting the nuclear factor-κB (NF-κB) pathway. |